Latest / Zero Friction / Modernizing Orthopedic Care Through AI & Patient Access with Dr. Jason Jones|| Zero Friction Podcast

Transcript

Modernizing Orthopedic Care Through AI & Patient Access with Dr. Jason Jones|| Zero Friction Podcast · Zero Friction

• Terry Coutsolioutsos/RevRx AI: Well, welcome folks to the ⁓ Zero Friction podcast. I have a really exciting guest today, Dr. Jason Jones, who is a board certified orthopedic surgeon. He's been doing knees and shoulders for more than 13 years right now. he is up a practice in Nashville, Tennessee, and we're excited to have him. So Jason, if you could just give us a little background on yourself as a specialist as well as some background on your practice. Jason Jones: Well, thanks for having me, Terry. am an orthopedic surgeon by training. Well, what that means is I I did my four years of medical school and then I mashed into an orthopedic residency. ⁓ did my orthopedic residency on Long Island in New York. I spent five years learning the basics of orthopedics at that point. That's everything from foot and ankle to neck surgery to trauma, which was really actually high volume in Long Island, unfortunately. And then after finishing my residency, I went to ⁓ the city. I was there for about two years. ⁓ there I specialized first with sports medicine. So I spent a lot of time working with all the way from high school teams to the professional level. spent ⁓ a little bit more than two years doing that. ⁓ then I did my last fellowship, which is kind of a focused learning on a certain body part or a certain specialty or a certain technique. And that last portion was done in Nice, France, where I just studied shoulder surgery. And that was about a four month process. following that, I turned around and went back close to home to Nashville, Tennessee. It's where my wife's from and it was ⁓ I grew up in small town Tennessee. But it was always kind of written, you know, in the stars that we'd be in Nashville. We kind of I knew that from the day that I met my wife. And we back to Nashville, Tennessee, and we've been there ever since. I quickly after going back, I joined a small private practice. And by small, I really do mean small. It was me and one other physician. And we've grown from patient volume quite a bit since then. But from a provider standpoint, we haven't grown ⁓ overly Terry Coutsolioutsos/RevRx AI: Yeah. Jason Jones: the abundantly in those thirteen years. Terry Coutsolioutsos/RevRx AI: That's great. Well, Nashville is a huge healthcare town. think one of the largest hospital corporations in America is based out of Nashville with HCA. it's a great healthcare town. so tell me a little bit about the practice and like how your practices evolved over the last 10 to 15 years with healthcare changes and patients and all that type of thing. Jason Jones: evolving quickly in a lot of different ways. So I I can't, you know, just sum it up with one specific example, but ⁓ practice ⁓ evolved from services offered standpoint, from a ⁓ what pa patient expectation standpoint, and the way medicine's delivered. All that's changed significantly over the last 13 years. what's what's changed is the economics of medicine, which are constantly evolving, really at kind of at warp speed right now. Terry Coutsolioutsos/RevRx AI: It's crazy, you know, and I hear that quite a bit from kinds of healthcare practices that, you know, the volume is getting massive. The of the patients are changing. know, the economics in healthcare, you know, are probably really challenging in terms of trying to run a practice with higher volumes with the capacity meet patient expectations around experiences. ⁓ What are you finding that are the biggest challenges or what are the biggest sort of hurdles for you as a practice today and what are some of the things that you're trying to and transform around? Jason Jones: So our our number one goal, our number one that we're trying to overcome is just providing the best patient care possible. And that has been true from day one, that'll be true until the day I retire. And that's just something we always keep in focus within the practice, because if we're not doing the best job we can do, then we're doing something wrong and we need to we need to be better. Now, what that means is changing. It's changed over the last two years, over the last five years, over the last 10 years. The biggest problem we have with patient d delivering best quality and service to the patient is accessibility, right? the patient volume, you kind of referenced this a second ago, is as high as it's ever been. We have more patients than we've ever had, ⁓ for better or for worse. The model actually encourages more patient visits. So that the current reimbursement model in medicine, you're rewarded for the more patients that you see. ⁓ from a provider standpoint, I only have a set amount of of time during the day. So if I have, you know, 40 units of time to give, Terry Coutsolioutsos/RevRx AI: Yep. Yep. Jason Jones: But I'm being asked to see 50 patients. there's a number crunch there. And trying to figure ⁓ how to make that work ⁓ has been like a tricky aspect of medicine, especially in the private sector. Some of the hospital-based ⁓ are able to overcome that because there is a built-in safety net by the hospital for either collections for reimbursement. They have a large, extremely large staff ⁓ You know, a a big business arm behind them. There's a big access to ancillary and potentially they're rewarded for introducing patients into their ancillary service. but for a small private practice, providing access for a growing number of patients has been a challenge. ⁓ Terry Coutsolioutsos/RevRx AI: Yeah, you know, I know like probably 10 years ago, there was a big move in healthcare where hospitals were purchasing private practice groups. And I know that when you and I discussed earlier that, you know, there's kind of a shift back to, you know, going back into the private practice arena, but like, you know, how do you accommodate, like, are you using new technology? Are you, phasing in different levels of service in terms of like a mid-level nurse practitioner or PAs or how are you accommodating the higher volumes of your patients? care is number one and I love that you say that because the of care is what we're all here about whether you're on the ⁓ giving or the receiving end and I'm just curious how you and your practice are sort of evolving to... maintain that level of care even though there's friction or inertia coming from you in multiple angles. Jason Jones: Well, the the two things you just mentioned are two resources we've utilized already, ⁓ mid levels, which is the Is the oldest solution for this problem. mid-levels being physicians' assistants and nurse practitioners. The I I've been blessed to have excellent mid-levels my entire career. I currently have two fantastic mid-levels that really do streamline the process for me. And what we are able to ⁓ utilize to do is to see kind of standardized patient visits, ⁓ patient visits that are they're they're trained to do and that they can do. without my direct oversight. And that enc encompasses maybe of our patient visits. They're long-term follow-up visits, ⁓ sometimes just a ⁓ post-surgical So patients that have already undergone their primary treatment, ⁓ it's just more of they're still in that follow-up window. and that that works. it's not always ideal, but for you know the given parameters around having a private practice in this medical economy, that that is a solution that a lot of practices incorporate. there is some oversight needed. You have to make sure that your mid-levels are well trained, that they understand sometimes some more of the nuances of your specific specialty, because they have to be aware at all times that nothing's being missed. as long as the mid-levels are well trained, they're good with people, like that that model helps. And it's almost necessary in a lot of specialties, especially surgical specialties. The other thing you mentioned was technology. That's a more recent implementation for us, but we've incorporated ambient dictation, which ⁓ saved me 45 minutes to an hour a day. It saved my entire team the same amount of time. So over the course of week, I think, you know, me and my two primary mid-levels, we've gotten probably six hours back, which is Terry Coutsolioutsos/RevRx AI: Great. Jason Jones: unbelievably valuable. the electronic medical records, which ⁓ ⁓ ⁓ been kind of a standard in medical practices for a while. we've just recently kind of incorporated that into our billing system, into our our note-taking system. So the accessibility for the other parties that we have to work with being you know ⁓ billing carriers, sometimes ⁓ third parties that you know patients need to transfer medical records to all that has become much more streamlined as well, which has also probably saved us, you know, an hour to two hours a week. Terry Coutsolioutsos/RevRx AI: Well, good. mean, you're able to clip an hour here and clip an hour there. Has AI entered your practice yet terms of low impact? Maybe it's just informing, educating, things that are easy questions to answer. Has played a role yet? Or are you just looking for the future on how AI can enter into your practice from a health care perspective? Jason Jones: Mm-hmm. Well, both. AI is is very prominent in healthcare. Now on both sides, and and by I'm splitting sides by saying that, but on the you know insurance reimbursement side, AI has very much already been implemented to review provider notes, to check for check for ⁓ you know insurance validity, to follow up ⁓ surgical necessity, things like that. They can they now kind of scan these provider notes to make quick judgments on that. And then from our standpoint, we standardize a lot of the things that we are able to do. Most importantly, what I mentioned earlier was ambient dictation, which essentially is that there's a recording and process. So all the entire interaction between myself and a patient is recorded. And then that's distilled down into a medical note, which is the most useful product of AI that I've experienced yet as a healthcare provider. I also use AI to do some quick just data search ⁓ a lot of times that's like like codes. because there's a lot of medical coding that insurance companies require. I mean there's, you know, tens of thousands of codes and it's it's it's impossible for any provider to know even 50% the codes that they use on a routine basis. So Terry Coutsolioutsos/RevRx AI: Thanks Jason Jones: Quick code searches with AI is is is very helpful. Terry Coutsolioutsos/RevRx AI: It's crazy because the whole medical reimbursements, mean, there are specialists that, you know, it's created a whole occupation for medical reimbursement specialties, right, because it's so complicated and government makes it so easy for us to get paid for the things we do sometimes. So the patient's changing. ⁓ sure your patients are more informed than ever to not, you know, not just with the internet. Now you have, now you have AI telling patients about, you know, Jason Jones: Mm-hmm. Mm-hmm. Terry Coutsolioutsos/RevRx AI: what's going on and how they should be treated and what their options are. Has that changed anything from like when you're engaging with patients in terms of the conversations you have today versus maybe a year or two ago? Jason Jones: It does. ⁓ a lot of times we have patients come in that are looking for something as opposed to looking for answers. And not ⁓ universally case by any means, but it's it's much more common now where a patient comes in and tells me, ⁓ I've shoulder pain for three months. I've tried physical therapy, I've taken anti-inflammatories. AI now tells me I need an MRI. Can you order an MRI for me? ⁓ it doesn't kind of Terry Coutsolioutsos/RevRx AI: Right? Right? Jason Jones: play out that simply, but it's that that is a thing where patients come in and they have a very specific request. and that is different. That's much more common now. The ⁓ other I see with AI is ⁓ patients tend to go down a rabbit hole. And it's just it's the it's the Google Doctor syndrome. It's that they are that that they they have a symptom and a symptom can represent 25 different, you know, pathologies. Terry Coutsolioutsos/RevRx AI: Mm. Jason Jones: And sometimes there's a fixation on the wrong pathology. And that's just where you need a provider with experience and you know the medical knowledge to distill what really is a risk and what's not. ⁓ but so the the the so the Google Doctor syndromes certainly magnified now that AI is is so accessible. Abs absolutely. Yeah. Terry Coutsolioutsos/RevRx AI: I am AI doctors, right? Instead of Google doctors. So there'll probably be a new stream of patients coming into healthcare now, will play, ⁓ you're on the other side of it and you're the doctor, that's certainly, it bring challenges at times too, I'm sure. Jason Jones: It can. And I I think for what I do in orthopedics, d generally patients that they have tr trouble with activity. They have joint pain. There's something that they want to do and they can't do anymore. So for a patient to seek out an orthopedic isn't always a stretch. You know, that there's I don't think there's a whole lot of fear in the system right now about orthopedics. But ⁓ but a patient's limited, the patient knows that they're limited. They can feel it. Their knee hurts, their shoulder hurts. Terry Coutsolioutsos/RevRx AI: Right? Jason Jones: So for them to seek out an orthopedic provider isn't typically a big reach despite their feeling on the medical system. There is this kind of growing distrust within the medical system that, you know, maybe you are are unaware of. But there is a concern of especially about some ⁓ medical providers that they can be misleading, you know, that they they treat diseases, they don't prevent diseases. That's kind of a a little bit of a mantra right now in certain communities. Terry Coutsolioutsos/RevRx AI: Yeah. Jason Jones: ⁓ so I I think that's challenging for a a sector of physicians. Terry Coutsolioutsos/RevRx AI: Well, and I think healthcare is all moving in that direction. so what I'd love to hear more about is like, so the practice today and where do you see your practice going in the future? So, as all these changes are coming, AI, preventative healthcare, home healthcare, just people wanting different levels of care when they want it, where they want it. What are you in your practice doing to sort of accommodate like this new consumer of healthcare? Jason Jones: Yeah. So w when you say consumer healthcare, that encompasses this kind of growing sector of of healthcare that I think a lot of times gets called the wellness sector. It's growing quickly. It's not necessarily led by medical practitioners in a lot of cases. would actually I I'm completely guessing here, but I I would I would say ⁓ less than three-fourths or three-fourths of those businesses are not led by medical providers. So ⁓ maybe a quarter of them actually are, you know, medically directed. that is introducing treatment regimen that patients ⁓ research their own. They they hear about it through different resources. They're curious. They believe in it. And all this is important. And then they seek it out on their own and they can freely purchase these services, these, you know, the modalities, the medications completely on their own. ⁓ so at that point we you know, the these businesses, these wellness centers, they're just supplying a product. and there's a role for that. There's absolutely a role for that. It's a it's a growing part of medicine. And currently there's not a and lumping this all together. I mean, the wellness sector encompasses everything from like IV therapy, which actually is very effective and has tons of, you know, data supporting this for, you know, ⁓ you ⁓ decades. then There's the peptide sector, which is kind of new and at this time And when to say ⁓ say peptides is very confusing because ⁓ insulin's a peptide. Insulin's saved ⁓ ⁓ of millions of lives. Like ⁓ like that, we we can't really drop insulin into this peptide market. But there's the newer peptides that have been really ⁓ publicized ⁓ recently, there's a lot of excitement about them. ⁓ Terry Coutsolioutsos/RevRx AI: You Jason Jones: But there's not much research around them. ⁓ my general idea is that they're they're safe and they can be effective for certain patients. But I think what's interesting is that patients are researching these, coming up coming up with their own conclusions on them, and then seeking them out on their own without any kind of prescription or necessarily medical recommendation to use these. And that that's new in healthcare. I can't think of any other. specific like medication these are typically injectables. this is this isn't a ⁓ this isn't typically a cream you're rubbing on your joint. I mean these are things you're actually putting, you know, more substantially in your body. And I can't think of another example where just the consumer market has sought out a medication ⁓ any kind of treatment to that degree. Terry Coutsolioutsos/RevRx AI: It's kind of crazy. And you we had, we had the Google doctor and then we had the AI doctor. And now you think about peptides and I think about the Facebook doctor now, right? So, ⁓ you know, who aren't really doctors by the way, but you know, it exploding. And I think the peptide market, I I think Eli Lilly sold $36 billion last year in GLPs. And I think that the entire peptide market is Jason Jones: Yeah. Terry Coutsolioutsos/RevRx AI: getting close to $100 billion a year in the US just to throw out some macroeconomic factors. So you're right, it's increasingly becoming more ⁓ and acceptable. ⁓ at the same time, I think that, you know, how does a practice, an orthopedic practice sort of embrace that energy and that acceptance, right? And that... ability to engage patients with a peptide. Maybe, you know, I'm sure there are peptides with peptide just about for anything. I'm sure there are peptides for joint pain or, you know, things like that. How do you embrace that in your practice? Do you think one day does that become a part of your practice? that, is that off to the side of your practice? How does, or a part of your practice at all? Jason Jones: We are making it part of our practice cautiously. ⁓ I'm sorry, what'd you say? Terry Coutsolioutsos/RevRx AI: That's exciting. That's exciting. That's great. Jason Jones: Yeah, I it's it it's think it's necessary to kind of accept the evolution of of medicine. ⁓ the ⁓ I I've done my own research on peptides and I I typically don't recommend things that I haven't tried myself. So I've most of the ⁓ calm mainstream peptides I've I've tried myself as well. in general, like peptides ⁓ are safe, which is incredibly important. peptides taken in the Correct amounts are a safe treatment. Now, how effective they are can change from one person to another. And the placebo effect is incredibly real. that that's a bad thing. If a patient, I think, believes in their treatment regimen and they feel better, then we've accomplished what we're trying to accomplish. I of really paramount here, though, is just following the scientific method, being ⁓ we to track what these medications are doing, how they affect patients over time. ⁓ And we have to be prepared to adjust if there are issues with these medications. There's still a lot of data coming out about GLP ones. And in general, GLP ones have are are safe. They're unbelievably effective. But there are some things that we still don't really understand. People's heart rate variability ⁓ decreases when they're on GLP ones. And what does that mean? Terry Coutsolioutsos/RevRx AI: Yeah. Jason Jones: It's hard to say exactly what it means, but it it it does in some way suggest that they're just their bodies are not adapting to normal recovery that the way they were prior to the GLP ones. there's concerns with bone mineralization with GLP ones, but none of this has necessarily been shown in in structured ⁓ at this point. So it's really a matter of the medical world, like the the physicians, the providers, the the research scientists. tracking these and really putting a lot of time into seeing are there concerns ⁓ how these affect patients over time. and I think that that's our role as like the scientific community to try to identify any concerns or potential problems with these medications. Terry Coutsolioutsos/RevRx AI: think that's great too that you think about the gray market and the peptide arena, Again, have companies like Hems and Hers and Roe and all these sort of online pharmaceutical companies that have physician prescriptions and things like that that ⁓ they really engage you. fill out a form online and ⁓ you it in and then ⁓ they you drugs, right? And with some needles. Jason Jones: Mm-hmm. Mm-hmm. Terry Coutsolioutsos/RevRx AI: And so, you know, as I think about it, like what a, if you're a patient wanting to go take a peptide of any kind, why wouldn't you go to the doctor that you're currently going to anyhow? So I think it's, you you pivoting to this is really not two things. One is it's great for your patients. Number one, that they, they have a clinician who they can trust that is, you know, scientifically in board certified and a specialty and they practice medicine. What a better way to get a prescription for a peptide than to buy it off of Facebook or another market. So I think that's a great pivot there. it's probably a really good thing for ⁓ from a business perspective too, and ⁓ a practice. It's probably a great way to keep your patients engaged over longer period of time as well, I would imagine, ⁓ and better experiences. Jason Jones: Mm-hmm. Mm-hmm. Mm-hmm. I think a lot of patients are looking for these medications. as as long as ⁓ feel like it's an appropriate treatment regimen, it's probably in everybody's best interest for us to distribute it. and I'm saying that blanketly to like a whole wellness sector. And obviously, we have to pick and choose what ⁓ peptides, medications, what supplements we ⁓ should to patients that can help. provide the best outcome and and I think our our role is to provide to provide direction. Terry Coutsolioutsos/RevRx AI: awesome too. mean because you know and from an orthopedic perspective I'm sure there's a there's probably a group of peptides there too right because they're not all subcutaneous some of them are oral some of them are nasal I mean there's all sorts of different ways to ingest the peptide correct? Am I wrong? Jason Jones: That no, you're absolutely correct. ⁓ subcutaneously is kind of the most effective way. So you know the small shot typically in the ⁓ is for almost every peptide, there I can think of one or two that that's not the preferred method, but for the other ⁓ and twenty kind of marketed peptides right now, that's the best way to to take the medication. Terry Coutsolioutsos/RevRx AI: So we have the peptide market, have wellness. emerging space, I think, in healthcare is concierge medicine part two. And is that something that you're considering for your practice as well? Jason Jones: It is. ⁓ the idea behind concierge from our perspective is access, time, and availability. And I we started this conversation discussing what the the difficulties are in medicine right now. And the squeeze is that I need to see more patients. I need to provide more access when I don't have the time and the staff to do it to the degree into The depth that I would like to, especially in the medical world where things are confusing. I I think a lot of patients don't understand the details of medicine, of orthopedics, of the treatments recommended, even after we've had the discussion. This is an entirely new concept, majority of patients. So in order to provide that extra time, the concierge space gives us a window ⁓ give patients more accessibility to. have conversations after their appointment, clarifying confusion that they may have, you know, asking for answers to questions that they, you know, they didn't think of until they were in their car on the way home, ⁓ and also giving more time to patients during the consultation. Terry Coutsolioutsos/RevRx AI: And your time problem, I don't think, is going to change. It's not going to get better either, with the aging demographics as well between ⁓ baby boomers and the Gen Xers, at least in your practice of time frame. the math behind it is not going to support less. You're only going to have to serve more. And so that concierge space is probably, how do you reach that customer? Have you thought about how you're going to go try to connect with that customer and who that, not but who that patient would be, ⁓ that from a concierge perspective might be? Jason Jones: I've thought about it. We are close to un kind of unrolling this program. We you but we we currently have a large patient base. So our our goal here is to provide more access ⁓ in time to the patients that choose it without Terry Coutsolioutsos/RevRx AI: ⁓ good. Right. Jason Jones: Isolating the patients that that don't choose to follow this path. so ⁓ that far as like marketing, getting the word out there, it's different with orthopedics because most concierge models they follow the medical model where patients ⁓ have to six follow month follow-ups routinely. They'll be seen by their primary medical doctor three to four times a year. And if they have any kind of acute illness, then that's also. kind of built in and offer during that that same window. With orthopedics, more often than not, a patient has an acute event, we treat that event, they get better and they no longer require our services. So when we offer the concierge model, I one of the big questions is, you know, what patient are we actually kind of going after? And orthopedics does encompass something beyond the ACL injury, beyond the rotator cuff injury, beyond those acute injuries. I think there's the patients with chronic joint pain. ⁓ there's also the families. There's the families with young kids who are active in sports where, you know, injuries are unfortunately kind of part of that of their of their normal ⁓ you know, activity like with their normal lives. ⁓ so I think that those a lot of times those are the patients that we're kind of looking at for the long term concierge model. Terry Coutsolioutsos/RevRx AI: Mm. Yeah. Right. Jason Jones: as far as reaching ⁓ ⁓ plan on doing it through ⁓ our current ⁓ base, just maybe starting an email marketing campaign. ⁓ there's gonna be information around our office, and then we'll we'll do kind of a small marketing campaign within Nashville as well, just to reach out to our current physician providers, to our current, you know, patient large of Patient focused whether that be in the gyms, whether that you know be in like some of the larger workplaces, and just kind of let them know that we, you know, we're here, we're doing this. ⁓ it's something you'd like to look into, you know, contact us here. And then the last portion of this is kind of within the surgical realm. So when I when we start offering surgeries, especially joint replacements, something that's very standardized, something that has a ⁓ eight-month window from consultation to kind of pre-treatment to the surgery to the post-treatment. We want to package that as also kind of a concierge plan. So instead of signing up for a a multi-year or like a membership model, we would just say, you know, over the six to nine months, you have access to, you know, these preferred modalities, to these preferred treatment ⁓ algorithms, to these If you want access to peptides, we can provide that. And we're going to optimize you on the front end prior to the surgery. We'll execute the surgery. And then on the after the surgery, you will have that same access and you're going to follow a protocol that we kind of really invest in and work with you on more of a basis as opposed to the current medical model where we might see a patient every you ⁓ two weeks. After some kind of procedure. Terry Coutsolioutsos/RevRx AI: Okay, or six or eight weeks or you know, it's my mom just had a couple hip replacements last year. And so I, I do understand that kind of process and routine and any thoughts of like, you know, engaging in an app or anything like that as well, you know, just for, you know, education information, you know, SMS engagement, notification engagement, that's, that's sounds like a very cool thing to do. And, and it's smart, because the I think as one of the frustrating things as a patient is like, it might take you six to nine months to get an appointment with a specialist. having, ⁓ just, not orthopedic wise, but I that in Florida, like to get a new neurologist, it'll take you six to nine months to get a new appointment with that specialty. So I think that you're providing access to care, you're providing you know, more knowledge, more information. And, you know, if that all happens, the goal is to have a better outcome. Probably everybody's very happy with that. Jason Jones: Yes. Yeah, that that that's always the goal. The the best outcomes, the best patient experience. these are all we have to keep in mind during very difficult times ⁓ these, ⁓ know, in these patients' lives. I mean, nobody wants to go to the doctor's office. I mean, I think that's universally true. Nobody wants to go to a doctor's office. ⁓ so our our goal here is that if you need to go to the physician's office, if you need to go see an orthopedist, let's make it as Terry Coutsolioutsos/RevRx AI: No. Jason Jones: smooth, understandable, and accessible as we possibly can. Terry Coutsolioutsos/RevRx AI: them in and get them out and get healthy again, right? Jason Jones: I do love the idea of the app though, and that's something that we've thought about, but I don't really know what pathway to go to explore that. Terry Coutsolioutsos/RevRx AI: You know, there's a couple different pathways. know app, you know, you're not going to go like market and try and sell it on the Apple, the podcast or the ⁓ store, I think there are different versions. But, you know, I just know for in general purposes, if you have an app that you're engaging with and that concierge services, a nice way to, you know, it's a different way to schedule. It's a different way to get informed. You know, you might even have patient information that they can have access to along the way. It's just, You know, in today's digital environment, people want to kind of have that info at their fingertips. And it's a pretty reasonable way to do it. And it's just another part of that overall experience that you're trying to create anyhow. Like you're trying to create an optimal experience for all your patients, whether they're concierge or non-concierge patients. I mean, your whole goal is to treat and create, you know, better lives and higher quality lives for people. So I think are all good things. It'll be interesting to see how you You go from this traditional model of I'm guessing 95 % plus of your work is built through a referral network or being on staff in hospitals and that type of thing. And now branching out into sort of ⁓ patient mode, right? Where you're trying to go capture new channel of patients in a new way. It's pretty exciting. Jason Jones: Mm-hmm. Yeah. I think what you said is really pertinent too about patient, you know, metrics and data. I mean what we're we're living in a age now where everybody loves their numbers. despite what those numbers mean, despite where they got them from, people loved numbers. People love to be able to track progress or to be motivated by, you know, some kind of setback. So that's something that we that I think about a lot. I've noticed how many people are wearing some kind of ⁓ metric wristwatch now. I mean, every like probably 50% of the people that ⁓ that that I take care of are you just you just just socially it's like almost everybody has some kind of like data tracking device. And we we want to provide that as well, especially like with these kind of more of like the the short term like package concierge models around surgery. ⁓ just so patients can really see with some sort of validity, you know, how have they improved from pre surgery to post surgery? The way we are looking at doing that right now are there's I mean, there's extensive lab panels that are easily obtainable. in the consumer market. And interpreting those is confusing. And like how how much do they actually mean is is debatable. But there like the the kind of lab, the data portion of it, which very much does give you a number that people like. you can see that number kind of change, stay the same or decrease over time. But for orthopedics, we things such as like your functional age, which is you know how how your body moves. Like how stable are you when you move? Like what's your balance? Like what's your leg strength like? So those are things that we want to track. And I think for our patients in the orthopedic world, that's what really resonates. they have better balance three after their surgery, that that means ⁓ that the world. That's gonna save them future injuries. That's gonna give them better quality of life. ⁓ And something that's trackable and meaningful. Terry Coutsolioutsos/RevRx AI: Mm. And it's so beneficial too. you know, so there's the trackable, there's the wearables, but then you also have the connected technology too with, you know, whether it's a Hume Health or a Whoop or all these things are now, you know, collecting, ⁓ know, how do you get that data back into your practice? That's the other part is that, you know, the information is being collected. sure there's bone, like I think on ⁓ Hume, actually have a bone density tracker on my on my Hume scale. So it's just sort of interesting how all that data can, and he said balance. know, as patients get older, it's, you after they have a surgery and if they don't fall down again, those are catastrophic things that happen to the elderly as well. So it's pretty how this is all kind of coming together with you ⁓ and your practice. when ⁓ this sort of you know, you sort of plan a transition or is it just sort of stay the course and go along with what you got and just sort of build these new components into the practice? do you plan on sort of looking at that? Jason Jones: Our current plan is a transition. So we will close one night our ⁓ brand, which is Nashville Knee and Shoulder Center, and we will Terry Coutsolioutsos/RevRx AI: Okay. Jason Jones: reopen the next morning as our new brand. ⁓ yeah, and I i it we don't want it to be that confusing. But as far as the signage on the door, I I do think it's going to be that cut and dry. We open the next morning as a different brand. ⁓ prior to that, ⁓ there's a whole website redevelopment that is going to have a lot of, you know, redirects and explanations and just trying to make sure there's continuity that people aren't confused that Terry Coutsolioutsos/RevRx AI: That's great. Jason Jones: Wait, where did my old doctor go? need to make that very clear. ⁓ and then as far as rolling out the the new offerings, that's something that, you know, we kind of hit on a little bit earlier. Well, ⁓ we need to kind of advertise to our patients that, hey, we are in fact doing this now. But then we also need to get to the community and let them know, hey, we are ⁓ the same physicians, providing the same. great care, but we also have these new offerings and and because of like kind of the changes in medical economics, we have a new name to go along with that. So Terry Coutsolioutsos/RevRx AI: really exciting, you know. It's always fun to have, you know, take your foundation and kind of boost from that baseline and go into the future. with, you know, wellness, with concierge, really excited to see what your practice is going to bring, Dr. Jones. And just wanted to say thank you for being here. It's been great hearing about your journey, you know, and the knee and shoulder arena, and to your practice in Nashville. And now you're ⁓ into new phase. Jason Jones: Yeah. you for having me, Terry. This has been a interesting enlightening conversation. Yeah. Terry Coutsolioutsos/RevRx AI: Jason, I appreciate it. Absolutely. by the way, for our listeners, Dr. Jones is on vacation. So he's really provided us an opportunity. You know, he's taken his personal time to be here. So I want to personally thank you for doing that as well. Jason Jones: You're very welcome. I've enjoyed it. Terry Coutsolioutsos/RevRx AI: Great, well thank you. Be well. Jason Jones: All right. Thanks, Jerry.